# Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3

> **NCT07167134** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Centre Paul Strauss** · enrollment: 264 (estimated)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** D1-3-5 radiotherapy
- **RADIATION:** D1-2-3 radiotherapy

## Key facts

- **NCT ID:** NCT07167134
- **Lead sponsor:** Centre Paul Strauss
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2028-10
- **Final completion:** 2030-04
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07167134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07167134, "Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07167134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*